Mark A. Miller & Bradford D. Gessner. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1625
1639.e7
.
John W. Ward, Nasamon Wanlapakorn, Yong Poovorawan & Daniel Shouval. 2023. Plotkin's Vaccines. Plotkin's Vaccines
389
432.e21
.
John W. Ward. 2021. Hepatitis B Virus and Liver Disease. Hepatitis B Virus and Liver Disease
169
203
.
Mélanie Drolet, Élodie Bénard, Mark Jit, Raymond Hutubessy & Marc Brisson. (2018) Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. Value in Health 21:10, pages 1250-1258.
Crossref
Mark A. Miller & Bradford D. Gessner. 2018. Plotkin's Vaccines. Plotkin's Vaccines
1532
1546.e7
.
Pierre Van Damme, John W. Ward, Daniel Shouval & Alessandro Zanetti. 2018. Plotkin's Vaccines. Plotkin's Vaccines
342
374.e17
.
John W. Ward & Pierre Van Damme. 2018. Hepatitis B Virus and Liver Disease. Hepatitis B Virus and Liver Disease
91
117
.
Angela Devine, Rebecca Harvey, Aung Myat Min, Mary Ellen T. Gilder, Moo Koh Paw, Joy Kang, Isabella Watts, Borimas Hanboonkunupakarn, François Nosten & Rose McGready. (2017) Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis. BMC Infectious Diseases 17:1.
Crossref
Joseph D. Njau & Lisa K. Cairns. (2016) A literature review on the economic benefits of vaccines in low and middle income countries: Evaluating progress in the era of ‘a decade of vaccines’ initiative. Vaccine Reports 6, pages 62-76.
Crossref
Y. Natalia Alfonso, Guiru Ding & David Bishai. (2016) Income Elasticity of Vaccines Spending versus General Healthcare Spending. Health Economics 25:7, pages 860-872.
Crossref
Susan Horton & Carol Levin. 2016. Disease Control Priorities, Third Edition (Volume 2): Reproductive, Maternal, Newborn, and Child Health. Disease Control Priorities, Third Edition (Volume 2): Reproductive, Maternal, Newborn, and Child Health
319
334
.
Rania A. Tohme, Jocelyne Andre-Alboth, Alexandra Tejada-Strop, Ran Shi, Jacques Boncy, Jeannot François, Jean Wysler Domercant, Mark Griswold, Erlantz Hyppolite, Paul Adrien & Saleem Kamili. (2016) Hepatitis B virus infection among pregnant women in Haiti: A cross-sectional serosurvey. Journal of Clinical Virology 76, pages 66-71.
Crossref
Solomon Chih-Cheng ChenMehlika ToyJennifer M. Yeh, Jung-Der Wang & Stephen Resch. (2013) Cost-effectiveness of Augmenting Universal Hepatitis B Vaccination With Immunoglobin Treatment. Pediatrics 131:4, pages e1135-e1143.
Crossref
Mark A. Miller & Alan R. Hinman. 2013. Vaccines. Vaccines
1413
1426
.
Pierre Van Damme, John Ward, Daniel Shouval, Steven Wiersma & Alessandro Zanetti. 2013. Vaccines. Vaccines
205
234
.
Maia Butsashvili, George Kamkamidze, Marina Topuridze, Dale Morse, Wayne Triner, Jack DeHovitz, Kenrad Nelson & Louise-Anne McNutt. (2012) Associated factors for recommending HBV vaccination to children among Georgian health care workers. BMC Infectious Diseases 12:1.
Crossref
Hong Anh T. Tu, Robin de Vries, Herman J. Woerdenbag, Shu Chuen Li, Hoa H. Le, Marinus van Hulst & Maarten J. Postma. (2012) Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam: Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making. Value in Health Regional Issues 1:1, pages 7-14.
Crossref
Malene L. BørresenAnders KochRobert J. BiggarKarin LadefogedMads MelbyeJan WohlfahrtTyra Grove Krause. (2012) Effectiveness of the Targeted Hepatitis B Vaccination Program in Greenland. American Journal of Public Health 102:2, pages 277-284.
Crossref
Melis Naçar, Fevziye Çetinkaya, Zeynep Baykan, Serpil Poyrazoğlu & Osman Günay. (2011) Adult Vaccination and Voluntary Vaccination State of Adults: a Study from Turkey. World Journal of Vaccines 01:02, pages 23-28.
Crossref